CA2235617A1 - Preparation therapeutique pour l'administration transdermique de substances actives - Google Patents

Preparation therapeutique pour l'administration transdermique de substances actives

Info

Publication number
CA2235617A1
CA2235617A1 CA 2235617 CA2235617A CA2235617A1 CA 2235617 A1 CA2235617 A1 CA 2235617A1 CA 2235617 CA2235617 CA 2235617 CA 2235617 A CA2235617 A CA 2235617A CA 2235617 A1 CA2235617 A1 CA 2235617A1
Authority
CA
Canada
Prior art keywords
active substances
therapeutic preparation
transdermal administration
additives
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2235617
Other languages
English (en)
Other versions
CA2235617C (fr
Inventor
Bodo Asmussen
Andreas Koch
Rudolf Matusch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19541260A external-priority patent/DE19541260A1/de
Application filed by Individual filed Critical Individual
Publication of CA2235617A1 publication Critical patent/CA2235617A1/fr
Application granted granted Critical
Publication of CA2235617C publication Critical patent/CA2235617C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA 2235617 1995-11-06 1996-09-21 Preparation therapeutique pour l'administration transdermique de substances actives Expired - Fee Related CA2235617C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19541260A DE19541260A1 (de) 1995-11-06 1995-11-06 Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut
DE19541260.5 1995-11-06
PCT/EP1996/004138 WO1997017061A1 (fr) 1995-11-06 1996-09-21 Preparation therapeutique pour l'administration transdermique de substances actives

Publications (2)

Publication Number Publication Date
CA2235617A1 true CA2235617A1 (fr) 1997-05-15
CA2235617C CA2235617C (fr) 2005-11-15

Family

ID=29403629

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2235617 Expired - Fee Related CA2235617C (fr) 1995-11-06 1996-09-21 Preparation therapeutique pour l'administration transdermique de substances actives

Country Status (1)

Country Link
CA (1) CA2235617C (fr)

Also Published As

Publication number Publication date
CA2235617C (fr) 2005-11-15

Similar Documents

Publication Publication Date Title
PL326497A1 (en) Pharmaceutic preparation for trancutaneous administration of active substances
AU681452B2 (en) Pernasal composition and pernasal preparation containing thesame
EP0316065A3 (en) Improved transdermal drug delivery device
EP0224837A3 (en) Dermatologically active pharmaceutical compositions having liposomes as the substantive carriers
TW250435B (fr)
CA2181742A1 (fr) Reduction de l'irritation de la peau pendant l'administration de medicament par electrotransport
AU537874B2 (en) Polyacrylate topical pharmaceutical
CA2132865A1 (fr) Administration transdermique d'oxybutynine
CA2276445A1 (fr) Systeme therapeutique transdermique pour administrer des hormones
GB2316004A (en) Novel formulations for transdermal delivery of pergolide
CA2046014A1 (fr) Reduction ou prevention des irritations cutanees causees par des medicaments
IE893840L (en) Use of acetyl d-carnitines for treating glaucoma
WO1998002169A3 (fr) Nouvelles preparations pour l'administration de fluoxetine
CA2251966A1 (fr) Administration transdermique de dextromethorphane servant d'agent antitussif
IE873120L (en) User-activated transdermal therapeutic system
AU1950388A (en) Pharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same
EP0693479A4 (fr) Nouveau compose du type aconitine, agent antipyretique, analgesique et anti-inflammatoire
CA2235617A1 (fr) Preparation therapeutique pour l'administration transdermique de substances actives
CA2394471A1 (fr) Agent antipruritique a usage externe
WO2001041771A3 (fr) Systeme transdermique contenant de l'acide acetylsalicylique pour le traitement de la migraine
EP0097953A3 (fr) Compositions synergétiques de nalbuphine et de composés non narcotiques analgésiques
CA2251353A1 (fr) Dispositif pour administration transdermique de composes d'azapirone
EP0132772A3 (en) Fr-900216 substance obtainable by cultivating atcc 20577 for use as an active therapeutic substance and pharmaceutical antitumor composition comprising fr-900216 substance
CA2242406A1 (fr) Poison topo-isomerase ii et therapie associee a base de derives de bis-dioxypiperazine
AU1290797A (en) Topical application of opioid drugs such as morphine for relief of itching and skin disease or irritation

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130923